Dendreon and 3 Monster Stocks Getting Drop Kicked
Dendreon (NASDAQ:DNDN) is getting slammed (again) after it became known the SEC is investigating the company. Also a successful trial of Johnson & Johnson’s (NYSE:JNJ) drug Zytiga is super bad news for the speculative DNDN because JNJ is now competing head to head. Get ready for some serious whiplash in shares.
Don’t Miss: Starbucks Tries Out New Executive Blend.
Pfizer (NYSE:PFE): A study by Vanderbilt University concludes Zithromax, an antibiotic used for common infections, may increase the chance for rare, but deadly, heart problems. Zithromax is marketed by Pfizer (NYSE:PFE).
Bank of America Corporation (NYSE:BAC) hired Ray Wood, Galvin Wolfe and Jason Satsky from Credit Suisse (NYSE:CS). The will join the energy and power group. Shares of Bank of America Corporation are trading 1.08% lower today.
AIG (NYSE:AIG): The New York Fed has delayed offloading $1.7 billion of debt in its Maiden Lane III portfolio. They want to give the market more time to analyze the portfolio, according to Bloomberg, which cited an unnamed source. Shares of AIG (NYSE:AIG) are down 2.2%.
Don’t Miss: Walmart Makes More Money on Lower Prices.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.